Hologic to acquire Endomagnetics in $310M deal

Hologic (NYSE: HOLX) + is set to acquire breast surgical guidance company Endomagnetics for $310 million.

Endomag develops and sells breast surgery localization and lymphatic tracing technology. It makes products like the Magseed marker for magnetic tissue localization before surgery. It also develops the Magtrace lymphatic tracing injectable for breast cancer staging and the Sentimag platform that supports localization and lymphatic tracing.

“Endomag’s suite of solutions complements our existing breast surgery portfolio and will provide surgeons and radiologists with an expanded range of options to meet the individual needs of more patients undergoing critical breast cancer procedures,” Hologic President of Breast and Skeletal Health Solutions Erik Anderson said in a news release. “With a global footprint and a similar commitment to women’s health, we are excited about the potential of welcoming the Endomag team and o…

Read more
  • 0